JP2025510149A5 - - Google Patents
Info
- Publication number
- JP2025510149A5 JP2025510149A5 JP2024556464A JP2024556464A JP2025510149A5 JP 2025510149 A5 JP2025510149 A5 JP 2025510149A5 JP 2024556464 A JP2024556464 A JP 2024556464A JP 2024556464 A JP2024556464 A JP 2024556464A JP 2025510149 A5 JP2025510149 A5 JP 2025510149A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- recombinant polypeptide
- acid sequence
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22164163 | 2022-03-24 | ||
| EP22164163.2 | 2022-03-24 | ||
| PCT/EP2023/057681 WO2023180547A1 (en) | 2022-03-24 | 2023-03-24 | Mhc ib-mediated islet-antigen-specific immunosuppression as a novel treatment for type 1 diabetes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025510149A JP2025510149A (ja) | 2025-04-14 |
| JP2025510149A5 true JP2025510149A5 (https=) | 2026-03-12 |
Family
ID=81327177
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024556464A Pending JP2025510149A (ja) | 2022-03-24 | 2023-03-24 | １型糖尿病の新規治療法としてのＭＨＣ Ｉｂ仲介膵島抗原特異的免疫抑制 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20250205323A1 (https=) |
| EP (1) | EP4499133A1 (https=) |
| JP (1) | JP2025510149A (https=) |
| KR (1) | KR20240167684A (https=) |
| CN (1) | CN118922202A (https=) |
| AU (1) | AU2023238308A1 (https=) |
| CA (1) | CA3255483A1 (https=) |
| CL (1) | CL2024002839A1 (https=) |
| CO (1) | CO2024012945A2 (https=) |
| IL (1) | IL315756A (https=) |
| MX (1) | MX2024011668A (https=) |
| WO (1) | WO2023180547A1 (https=) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3400069A4 (en) * | 2016-01-04 | 2019-09-25 | Cour Pharmaceuticals Development Company Inc. | Particles for the Encapsulation of Fusion Proteins with Bundled Epitopes |
| EP3630809A1 (en) | 2017-05-23 | 2020-04-08 | Bruttel, Valentin | Combinations of mhc class ib molecules and peptides for targeted therapeutic immunomodulation |
-
2023
- 2023-03-24 AU AU2023238308A patent/AU2023238308A1/en active Pending
- 2023-03-24 US US18/849,139 patent/US20250205323A1/en active Pending
- 2023-03-24 CN CN202380029747.7A patent/CN118922202A/zh active Pending
- 2023-03-24 KR KR1020247035504A patent/KR20240167684A/ko active Pending
- 2023-03-24 MX MX2024011668A patent/MX2024011668A/es unknown
- 2023-03-24 CA CA3255483A patent/CA3255483A1/en active Pending
- 2023-03-24 EP EP23714707.9A patent/EP4499133A1/en active Pending
- 2023-03-24 WO PCT/EP2023/057681 patent/WO2023180547A1/en not_active Ceased
- 2023-03-24 JP JP2024556464A patent/JP2025510149A/ja active Pending
- 2023-03-24 IL IL315756A patent/IL315756A/en unknown
-
2024
- 2024-09-23 CL CL2024002839A patent/CL2024002839A1/es unknown
- 2024-09-25 CO CONC2024/0012945A patent/CO2024012945A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2017380449B2 (en) | Cell expressing a car and a transcription factor and its use | |
| KR101902029B1 (ko) | 감염성 질환, 자가면역 질환, 동종인자에 대한 면역 반응, 알레르기 질환, 종양, 이식편 거부 및 유전자 요법 또는 유전자 백신접종을 위해 사용되는 바이러스 벡터에 대한 면역 반응의 예방 및/또는 치료에 사용하기 위한 면역원성 펩티드 | |
| JP2020521000A5 (https=) | ||
| EP3004137A1 (en) | Improved method for the detection, preparation and depletion of cd4+ t lymphocytes | |
| JPH07285996A (ja) | 抗原特異的活性化ｔリンパ球、その検出及び使用 | |
| JP2012516140A5 (https=) | ||
| JPH07503362A (ja) | レコンビトープペプチド | |
| CN101451145A (zh) | 基于t细胞表位的结核基因疫苗及其制备方法和应用 | |
| JP2010535504A5 (https=) | ||
| US6245904B1 (en) | Recombinant polypeptide based on the primary sequence of the invariant chain with at least one primary sequence of a specific T-cell epitope or a protein derivative and nucleic acids coding for this recombinant polypeptide | |
| US6989146B2 (en) | Stress proteins and peptides and methods of use thereof | |
| US5000952A (en) | Polypeptide pertussis toxin vaccine | |
| JP2025510149A5 (https=) | ||
| JP2025513720A5 (https=) | ||
| AU2001285427A1 (en) | Stress proteins and peptides and methods of use thereof | |
| JP2022532271A5 (https=) | ||
| JP2025510786A5 (https=) | ||
| JP2025514872A5 (https=) | ||
| CN102219858A (zh) | 微小隐孢子虫ctl多表位基因和融合蛋白及其应用 | |
| US7608683B2 (en) | Stress proteins and peptides and methods of use thereof | |
| JP2021045150A5 (https=) | ||
| CN102657854A (zh) | 多表位疫苗yl66以及在制备肿瘤治疗性疫苗中的应用 | |
| JP2022505107A5 (https=) | ||
| JP2019205449A (ja) | 免疫用ペプチド、免疫用ペプチドの製造方法、それを含む免疫疾患用医薬組成物、および免疫疾患の治療方法 | |
| WO1996016083A1 (en) | Peptides endowed with antiinflammatory activity |